Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.62M | 92.07M | 105.64M | 81.41M | 79.66M | 73.92M |
Gross Profit | 23.01M | 24.12M | 25.01M | 24.48M | 31.43M | 16.69M |
EBITDA | 6.15M | -686.00K | 7.13M | 7.35M | 19.92M | 15.87M |
Net Income | -5.01M | -12.48M | -3.19M | -4.67M | 6.86M | 2.78M |
Balance Sheet | ||||||
Total Assets | 464.92M | 447.57M | 478.35M | 500.51M | 529.27M | 337.35M |
Cash, Cash Equivalents and Short-Term Investments | 52.88M | 50.01M | 70.17M | 107.11M | 254.07M | 40.59M |
Total Debt | 40.01M | 63.39M | 60.83M | 70.59M | 57.85M | 115.58M |
Total Liabilities | 123.27M | 109.55M | 115.04M | 100.99M | 80.86M | 153.62M |
Stockholders Equity | 304.06M | 300.52M | 325.31M | 347.29M | 404.01M | 139.61M |
Cash Flow | ||||||
Free Cash Flow | -13.06M | -20.04M | -34.23M | -72.87M | -18.03M | -22.18M |
Operating Cash Flow | 603.00K | -4.29M | -23.49M | -35.25M | -6.42M | -13.93M |
Investing Cash Flow | -14.96M | -15.47M | 15.31M | -37.06M | 19.39M | 510.00K |
Financing Cash Flow | 15.58M | -5.85M | -25.26M | -60.28M | 204.88M | 30.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $36.70B | 12.21 | -10.39% | 1.84% | 8.50% | -7.32% | |
49 Neutral | $95.46M | ― | -1.27% | ― | -33.25% | 81.55% | |
47 Neutral | $114.39M | ― | -221.18% | ― | 52.31% | -2421.56% | |
42 Neutral | $73.61M | ― | -9.81% | ― | 86.59% | 55.95% | |
41 Neutral | $60.82M | ― | ― | -27.65% | 16.39% | ||
41 Neutral | $66.57M | ― | 307.38% | ― | -54.68% | 63.56% | |
40 Underperform | $128.82M | ― | ― | 308.47% | 76.84% |
On June 18, 2025, Emeren Group Ltd entered into a Merger Agreement with Shurya Vitra Ltd and Emeren Holdings Ltd, aiming to merge Emeren Holdings with Emeren Group, with the latter continuing as the surviving entity. An extraordinary general meeting (EGM) is scheduled for October 21, 2025, to vote on the merger, which, if approved, will transition Emeren into a privately held company, delisting its shares from the New York Stock Exchange. The board of directors recommends shareholders vote in favor of the merger, which could significantly impact the company’s market presence and shareholder structure.
The most recent analyst rating on (SOL) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Emeren Group stock, see the SOL Stock Forecast page.